Neuroone Medical Technologies (NMTC) Equity Average (2016 - 2025)
Historic Equity Average for Neuroone Medical Technologies (NMTC) over the last 12 years, with Q4 2025 value amounting to $6.7 million.
- Neuroone Medical Technologies' Equity Average rose 25862.0% to $6.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.7 million, marking a year-over-year increase of 25862.0%. This contributed to the annual value of $3.9 million for FY2025, which is 1164.01% up from last year.
- Neuroone Medical Technologies' Equity Average amounted to $6.7 million in Q4 2025, which was up 25862.0% from $7.6 million recorded in Q3 2025.
- In the past 5 years, Neuroone Medical Technologies' Equity Average registered a high of $14.5 million during Q1 2022, and its lowest value of $1.9 million during Q4 2024.
- Its 5-year average for Equity Average is $6.7 million, with a median of $6.4 million in 2021.
- Per our database at Business Quant, Neuroone Medical Technologies' Equity Average skyrocketed by 116106.12% in 2021 and then plummeted by 6477.82% in 2024.
- Neuroone Medical Technologies' Equity Average (Quarter) stood at $11.3 million in 2021, then decreased by 21.0% to $8.9 million in 2022, then crashed by 39.99% to $5.3 million in 2023, then tumbled by 64.78% to $1.9 million in 2024, then skyrocketed by 258.62% to $6.7 million in 2025.
- Its Equity Average was $6.7 million in Q4 2025, compared to $7.6 million in Q3 2025 and $4.7 million in Q2 2025.